Janney Montgomery Scott LLC Sells 642 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Janney Montgomery Scott LLC cut its holdings in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPHGet Rating) by 10.6% during the second quarter, Holdings Channel.com reports. The fund owned 5,390 shares of the company’s stock after selling 642 shares during the period. Janney Montgomery Scott LLC’s holdings in SPDR S&P Pharmaceuticals ETF were worth $228,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in XPH. Captrust Financial Advisors boosted its position in shares of SPDR S&P Pharmaceuticals ETF by 23.2% during the first quarter. Captrust Financial Advisors now owns 1,388 shares of the company’s stock worth $63,000 after purchasing an additional 261 shares in the last quarter. BNP Paribas Arbitrage SA boosted its position in shares of SPDR S&P Pharmaceuticals ETF by 17.5% during the first quarter. BNP Paribas Arbitrage SA now owns 4,375 shares of the company’s stock worth $198,000 after purchasing an additional 651 shares in the last quarter. Beacon Pointe Advisors LLC bought a new position in shares of SPDR S&P Pharmaceuticals ETF during the first quarter worth $210,000. Atria Wealth Solutions Inc. bought a new position in shares of SPDR S&P Pharmaceuticals ETF during the first quarter worth $211,000. Finally, J. Goldman & Co LP bought a new position in shares of SPDR S&P Pharmaceuticals ETF during the first quarter worth $297,000.

SPDR S&P Pharmaceuticals ETF Price Performance

Shares of NYSEARCA XPH opened at $41.84 on Thursday. The company’s fifty day moving average is $41.52 and its 200-day moving average is $41.88. SPDR S&P Pharmaceuticals ETF has a twelve month low of $37.94 and a twelve month high of $49.33.

SPDR S&P Pharmaceuticals ETF Profile

(Get Rating)

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Stories

Want to see what other hedge funds are holding XPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPHGet Rating).

Institutional Ownership by Quarter for SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Receive News & Ratings for SPDR S&P Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.